Literature DB >> 1951573

Mycotic vulvovaginitis: a broad overview.

B J Horowitz1.   

Abstract

The incidence of mycotic vulvovaginitis is rising dramatically in the United States mainly because of an increase in infections caused by Candida species. Accurate diagnosis depends on culture techniques that will yield correct identification of fungal pathogen(s). Recurrences are common and require culture specimens from sexual partners and appropriate antifungal therapy. The imidazoles and more recently the broader spectrum triazoles are used for vaginal therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1951573     DOI: 10.1016/s0002-9378(12)90725-5

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.

Authors:  Y Han; R P Morrison; J E Cutler
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 2.  Fungal infections: a growing threat.

Authors:  D M Dixon; M M McNeil; M L Cohen; B G Gellin; J R La Montagne
Journal:  Public Health Rep       Date:  1996 May-Jun       Impact factor: 2.792

3.  Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.

Authors:  Monika Sojakova; Denisa Liptajova; Miroslav Borovsky; Julius Subik
Journal:  Mycopathologia       Date:  2004-02       Impact factor: 2.574

4.  Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV-seropositive women.

Authors:  A Spinillo; G Michelone; C Cavanna; L Colonna; E Capuzzo; S Nicola
Journal:  Genitourin Med       Date:  1994-08

5.  Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysis.

Authors:  G Sood; P Nyirjesy; M V Weitz; A Chatwani
Journal:  Infect Dis Obstet Gynecol       Date:  2000

6.  New treatments for vulvovaginal candidiasis.

Authors:  S Faro
Journal:  Infect Dis Obstet Gynecol       Date:  1996

7.  Systemic vs. topical therapy for the treatment of Vulvovaginal Candidiasis.

Authors:  S Faro
Journal:  Infect Dis Obstet Gynecol       Date:  1994
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.